Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


30.10.2017

3 AJR Am J Roentgenol
1 Am J Surg Pathol
2 Ann Surg
1 Ann Surg Oncol
6 Anticancer Res
1 BMC Cancer
7 Breast Cancer Res Treat
3 Breast J
1 Cancer Epidemiol Biomarkers Prev
1 Clin Breast Cancer
1 Clin Cancer Res
2 Eur J Cancer
1 Eur Radiol
1 Exp Cell Res
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
3 J Natl Cancer Inst
1 Nature
1 Oncogene
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. DESTOUNIS S, Santacroce A
    Age to Begin and Intervals for Breast Cancer Screening: Balancing Benefits and Harms.
    AJR Am J Roentgenol. 2017 Oct 24:1-6. doi: 10.2214/AJR.17.18730.
    PubMed     Text format     Abstract available

  2. ABRAMSON RG, Lakomkin N, Hainline A, Kang H, et al
    The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival.
    AJR Am J Roentgenol. 2017 Oct 24:W1-W7. doi: 10.2214/AJR.17.18249.
    PubMed     Text format     Abstract available

  3. PATEL BK, Lee CS, Kosiorek HE, Newell MS, et al
    Variability of Postsurgical Imaging Surveillance of Breast Cancer Patients: A Nationwide Survey Study.
    AJR Am J Roentgenol. 2017 Oct 24:1-6. doi: 10.2214/AJR.17.17923.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  4. PATEL A, D'Alfonso T, Cheng E, Hoda SA, et al
    Sentinel Lymph Nodes in Classic Invasive Lobular Carcinoma of the Breast: Cytokeratin Immunostain Ensures Detection, and Precise Determination of Extent, of Involvement.
    Am J Surg Pathol. 2017;41:1499-1505.
    PubMed     Text format     Abstract available


    Ann Surg

  5. HEIL J, Richter H, Golatta M, Sinn HP, et al
    Vacuum-Assisted Biopsy to Diagnose a Pathological Complete Response in Breast Cancer Patients After Neoadjuvant Systemic Therapy.
    Ann Surg. 2017 Oct 23. doi: 10.1097/SLA.0000000000002572.
    PubMed     Text format    

  6. KUERER HM, Krishnamurthy S, Rauch GM, Yang WT, et al
    Optimal Selection of Breast Cancer Patients for Elimination of Surgery Following Neoadjuvant Systemic Therapy.
    Ann Surg. 2017 Oct 23. doi: 10.1097/SLA.0000000000002573.
    PubMed     Text format    


    Ann Surg Oncol

  7. TOPPS AR, Barr SP, Pikoulas P, Pritchard SA, et al
    Pre-operative Axillary Ultrasound-Guided Needle Sampling in Breast Cancer: Comparing the Sensitivity of Fine Needle Aspiration Cytology and Core Needle Biopsy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6090.
    PubMed     Text format     Abstract available


    Anticancer Res

  8. SHEIKH IA, Jiffri EH, Kamal MA, Ashraf GM, et al
    Lactoperoxidase, an Antimicrobial Milk Protein, as a Potential Activator of Carcinogenic Heterocyclic Amines in Breast Cancer.
    Anticancer Res. 2017;37:6415-6420.
    PubMed     Text format     Abstract available

  9. SHEIKH IA, Beg MA, Yasir M
    Molecular Interactions of Carcinogenic Aromatic Amines, 4-Aminobiphenyl and 4,4'-Diaminobiphenyl, with Lactoperoxidase - Insight to Breast Cancer.
    Anticancer Res. 2017;37:6245-6249.
    PubMed     Text format     Abstract available

  10. JEON D, Kim H, Nam K, Oh S, et al
    Cytotoxic Effect of Nano-SiO2 in Human Breast Cancer Cells via Modulation of EGFR Signaling Cascades.
    Anticancer Res. 2017;37:6189-6197.
    PubMed     Text format     Abstract available

  11. WAKIMOTO R, Ono M, Takeshima M, Higuchi T, et al
    Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells.
    Anticancer Res. 2017;37:6153-6159.
    PubMed     Text format     Abstract available

  12. DU J, Sun Y, Lu YY, Lau E, et al
    Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Anticancer Res. 2017;37:6141-6151.
    PubMed     Text format     Abstract available

  13. MATSUI A, Tatibana A, Suzuki N, Hirata M, et al
    Evaluation of Efficacy and Safety of Upfront Weekly Nanoparticle Albumin-bound Paclitaxel for HER2-negative Breast Cancer.
    Anticancer Res. 2017;37:6481-6488.
    PubMed     Text format     Abstract available


    BMC Cancer

  14. D'ALOISIO AA, Nichols HB, Hodgson ME, Deming-Halverson SL, et al
    Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer.
    BMC Cancer. 2017;17:692.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  15. ABADIE J, Nguyen F, Loussouarn D, Pena L, et al
    Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.
    Breast Cancer Res Treat. 2017 Oct 23. doi: 10.1007/s10549-017-4542.
    PubMed     Text format     Abstract available

  16. BOCK CH, Jay AM, Dyson G, Beebe-Dimmer JL, et al
    The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study.
    Breast Cancer Res Treat. 2017 Oct 24. doi: 10.1007/s10549-017-4521.
    PubMed     Text format     Abstract available

  17. DIRIX LY, Takacs I, Jerusalem G, Nikolinakos P, et al
    Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
    Breast Cancer Res Treat. 2017 Oct 23. doi: 10.1007/s10549-017-4537.
    PubMed     Text format     Abstract available

  18. TAN Q, Qin Q
    Does the elevation of CAMLs predict metastatic breast cancer patients' survival?
    Breast Cancer Res Treat. 2017 Oct 20. doi: 10.1007/s10549-017-4546.
    PubMed     Text format    

  19. SONKE GS, Hart LL, Campone M, Erdkamp F, et al
    Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
    Breast Cancer Res Treat. 2017 Oct 22. doi: 10.1007/s10549-017-4523.
    PubMed     Text format     Abstract available

  20. HAYES SC, Steele ML, Spence RR, Gordon L, et al
    Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials.
    Breast Cancer Res Treat. 2017 Oct 23. doi: 10.1007/s10549-017-4541.
    PubMed     Text format     Abstract available

  21. ALTUNDAG K
    Dose adjustment in obese breast cancer patients receiving neoadjuvant chemotherapy might have an impact on survival.
    Breast Cancer Res Treat. 2017 Oct 23. doi: 10.1007/s10549-017-4544.
    PubMed     Text format    


    Breast J

  22. OBA T, Ono M, Iesato A, Hanamura T, et al
    Chylous leakage after axillary lymph node dissection in a patient with breast cancer.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12934.
    PubMed     Text format    

  23. MERRILL RM
    Conditional relative survival among female breast cancer patients in the United States.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12933.
    PubMed     Text format    

  24. WHITWORTH PW, Cooper A
    Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12939.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  25. SERRANO-GOMEZ SJ, Fejerman L, Zabaleta J
    Breast cancer in Latinas: a focus on intrinsic subtypes distribution.
    Cancer Epidemiol Biomarkers Prev. 2017 Oct 20. pii: cebp.0420.2017.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  26. LEAL AD, Van Houten H, Sangaralingham L, Freedman RA, et al
    Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.
    Clin Breast Cancer. 2017 Sep 22. pii: S1526-8209(17)30422.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  27. PRICEMAN SJ, Tilakawardane D, Jeang B, Murad JP, et al
    Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain.
    Clin Cancer Res. 2017 Oct 23. pii: clincanres.2041.2017.
    PubMed     Text format     Abstract available


    Eur J Cancer

  28. VAN DAM PA, Tomatis M, Marotti L, Heil J, et al
    Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.
    Eur J Cancer. 2017;85:15-22.
    PubMed     Text format     Abstract available

  29. DAROLES J, Borget I, Suciu V, Mazouni C, et al
    Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful?
    Eur J Cancer. 2017;85:23-30.
    PubMed     Text format     Abstract available


    Eur Radiol

  30. ZHAO J, Zhang J, Zhu QL, Jiang YX, et al
    The value of contrast-enhanced ultrasound for sentinel lymph node identification and characterisation in pre-operative breast cancer patients: A prospective study.
    Eur Radiol. 2017 Oct 20. doi: 10.1007/s00330-017-5089.
    PubMed     Text format     Abstract available


    Exp Cell Res

  31. ZHU S, Wang X, Wang J, Lin J, et al
    CD21lo/medCD27+ proinflammatory B cells are enriched in breast cancer patients and promote antitumor T cell responses.
    Exp Cell Res. 2017 Oct 17. pii: S0014-4827(17)30561.
    PubMed     Text format     Abstract available


    Int J Cancer

  32. KEINAN-BOKER L, Levine H, Leiba A, Derazne E, et al
    Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31121.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  33. CHAKRAVARTHY AB
    Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:784-786.
    PubMed     Text format    


    J Natl Cancer Inst

  34. DESHMUKH AA, Shirvani SM, Lal L, Swint JM, et al
    Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  35. MEIER M, Orr N
    Genetic Determinants of Breast Cancer Risk in Childhood Cancer Survivors.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    

  36. MORTON LM, Sampson JN, Armstrong GT, Chen TH, et al
    Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    Nature

  37. MICHAILIDOU K, Lindstrom S, Dennis J, Beesley J, et al
    Association analysis identifies 65 new breast cancer risk loci.
    Nature. 2017 Oct 23. doi: 10.1038/nature24284.
    PubMed     Text format     Abstract available


    Oncogene

  38. LUCANUS AJ, Yip GW
    Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  39. DIMITROPOULOS K, Barmpoutis P, Zioga C, Kamas A, et al
    Grading of invasive breast carcinoma through Grassmannian VLAD encoding.
    PLoS One. 2017;12:e0185110.
    PubMed     Text format     Abstract available

  40. KANG HJ, Kim SW, Son SH
    The feasibility of a heart block with an electron compensation as an alternative whole breast radiotherapy technique in patients with underlying cardiac or pulmonary disease.
    PLoS One. 2017;12:e0184137.
    PubMed     Text format     Abstract available

  41. CHEN Z, Yang J, Li S, Lv M, et al
    Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
    PLoS One. 2017;12:e0182397.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: